NG101m
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NG101m, covering 2025-10-21 to 2025-10-21. Get the full timeline:
Most recent: Clinical Trial Update: NG101m Adjuvant Therapy in Glioblastoma Patients [Phase 1, Phase 2]